65 related articles for article (PubMed ID: 38731247)
1. Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.
Woo XY; Giordano J; Srivastava A; Zhao ZM; Lloyd MW; de Bruijn R; Suh YS; Patidar R; Chen L; Scherer S; Bailey MH; Yang CH; Cortes-Sanchez E; Xi Y; Wang J; Wickramasinghe J; Kossenkov AV; Rebecca VW; Sun H; Mashl RJ; Davies SR; Jeon R; Frech C; Randjelovic J; Rosains J; Galimi F; Bertotti A; Lafferty A; O'Farrell AC; Modave E; Lambrechts D; Ter Brugge P; Serra V; Marangoni E; El Botty R; Kim H; Kim JI; Yang HK; Lee C; Dean DA; Davis-Dusenbery B; Evrard YA; Doroshow JH; Welm AL; Welm BE; Lewis MT; Fang B; Roth JA; Meric-Bernstam F; Herlyn M; Davies MA; Ding L; Li S; Govindan R; Isella C; Moscow JA; Trusolino L; Byrne AT; Jonkers J; Bult CJ; Medico E; Chuang JH; ;
Nat Genet; 2021 Jan; 53(1):86-99. PubMed ID: 33414553
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations.
Meric-Bernstam F; Lloyd MW; Koc S; Evrard YA; McShane LM; Lewis MT; Evans KW; Li D; Rubinstein LV; Welm AL; Dean DA; Srivastava A; Grover JW; Ha MJ; Chen H; Huang X; Varadarajan K; Wang J; Roth JA; Welm BE; Govindan R; Ding L; Kaochar S; Mitsiades N; Carvajal-Carmona LG; Herlyn M; Davies MA; Shapiro GI; Fields RC; Trevino JG; Harrell JC; Doroshow JH; Chuang JH; Moscow JA
Mol Cancer Ther; 2024 Apr; ():. PubMed ID: 38641411
[TBL] [Abstract][Full Text] [Related]
3. Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early Experience.
Nishie R; Tanaka T; Hirosuna K; Miyamoto S; Murakami H; Tsuchihashi H; Toji A; Ueda S; Morita N; Hashida S; Daimon A; Terada S; Maruoka H; Konishi H; Kogata Y; Taniguchi K; Komura K; Ohmichi M
J Clin Med; 2024 May; 13(9):. PubMed ID: 38731247
[No Abstract] [Full Text] [Related]
4.
Ji W; Niu X; Yu Y; Li Z; Gu L; Lu S
Front Immunol; 2022; 13():955800. PubMed ID: 36405701
[TBL] [Abstract][Full Text] [Related]
5. Focus on PD-1/PD-L1 as a Therapeutic Target in Ovarian Cancer.
Dumitru A; Dobrica EC; Croitoru A; Cretoiu SM; Gaspar BS
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292922
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance.
Serra V; Wang AT; Castroviejo-Bermejo M; Polanska UM; Palafox M; Herencia-Ropero A; Jones GN; Lai Z; Armenia J; Michopoulos F; Llop-Guevara A; Brough R; Gulati A; Pettitt SJ; Bulusu KC; Nikkilä J; Wilson Z; Hughes A; Wijnhoven PWG; Ahmed A; Bruna A; Gris-Oliver A; Guzman M; Rodríguez O; Grueso J; Arribas J; Cortés J; Saura C; Lau A; Critchlow S; Dougherty B; Caldas C; Mills GB; Barrett JC; Forment JV; Cadogan E; Lord CJ; Cruz C; Balmaña J; O'Connor MJ
Clin Cancer Res; 2022 Oct; 28(20):4536-4550. PubMed ID: 35921524
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of chemotherapy resistance in ovarian cancer.
Ortiz M; Wabel E; Mitchell K; Horibata S
Cancer Drug Resist; 2022; 5(2):304-316. PubMed ID: 35800369
[TBL] [Abstract][Full Text] [Related]
8. Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization.
Miyamoto S; Tanaka T; Hirosuna K; Nishie R; Ueda S; Hashida S; Terada S; Konishi H; Kogata Y; Taniguchi K; Komura K; Ohmichi M
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740635
[TBL] [Abstract][Full Text] [Related]
9. Endometrial Cancer Patient-Derived Xenograft Models: A Systematic Review.
Tanaka T; Nishie R; Ueda S; Miyamoto S; Hashida S; Konishi H; Terada S; Kogata Y; Sasaki H; Tsunetoh S; Taniguchi K; Komura K; Ohmichi M
J Clin Med; 2022 May; 11(9):. PubMed ID: 35566732
[TBL] [Abstract][Full Text] [Related]
10. Tumor organoids: applications in cancer modeling and potentials in precision medicine.
Xu H; Jiao D; Liu A; Wu K
J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634
[TBL] [Abstract][Full Text] [Related]
11. Non-apoptotic cell death in ovarian cancer: Treatment, resistance and prognosis.
Chen J; Wei Z; Fu K; Duan Y; Zhang M; Li K; Guo T; Yin R
Biomed Pharmacother; 2022 Jun; 150():112929. PubMed ID: 35429741
[TBL] [Abstract][Full Text] [Related]
12. Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer.
Kang J; Lee JY; Lee S; Kim D; Lim J; Jun HR; Jeon S; Kim YA; Park HS; Kim KP; Chun SM; Lee HJ; Yoo C
Cancer Res Treat; 2023 Jan; 55(1):219-230. PubMed ID: 35410113
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates.
Cybula M; Bieniasz M
Oncotarget; 2022; 13():553-575. PubMed ID: 35359749
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in
West HJ; McCleland M; Cappuzzo F; Reck M; Mok TS; Jotte RM; Nishio M; Kim E; Morris S; Zou W; Shames D; Das Thakur M; Shankar G; Socinski MA
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35190375
[TBL] [Abstract][Full Text] [Related]
15. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
16. Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research.
Cybula M; Wang L; Wang L; Drumond-Bock AL; Moxley KM; Benbrook DM; Gunderson-Jackson C; Ruiz-Echevarria MJ; Bhattacharya R; Mukherjee P; Bieniasz M
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944908
[TBL] [Abstract][Full Text] [Related]
17. Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review.
Tanaka T; Nishie R; Ueda S; Miyamoto S; Hashida S; Konishi H; Terada S; Kogata Y; Sasaki H; Tsunetoh S; Taniguchi K; Komura K; Ohmichi M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502278
[TBL] [Abstract][Full Text] [Related]
18. PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer.
Sun Y; Lu D; Yin Y; Song J; Liu Y; Hao W; Qi F; Zhang G; Zhang X; Liu L; Lin Z; Liang H; Zhao X; Jin Y; Yin Y
Nat Commun; 2021 Aug; 12(1):5147. PubMed ID: 34446716
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
